CNS Pharmaceuticals (CNSP) Stock: Why It Moved Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $4.85 as of 12:05 PM ET, -0.02% vs the prior close of $4.85.
- Volume 400 shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CNSP is flat (-0.0%) to $4.85, a 1-month low, 4 down days in a row. Trading at $4.85 (intraday, 12:05 PM ET), -0.02% vs the prior close of $4.85. Day range $4.85–$4.85, opened at $4.85.
CNSP daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — CNSP is flat (-0.0%) to $4.85, a 1-month low, 4 down days in a row
- Trading at $4.85 (intraday, 12:05 PM ET), -0.02% vs the prior close of $4.85. Day range $4.85–$4.85, opened at $4.85.
- Volume was 400 shares, 0.1x its 50-day average of 6.05K — lighter than usual.
- Price is -11.0% vs its 50-day average ($5.45) and +4.8% vs its 200-day average ($4.63).
- 52-week range $1.90–$10.54; the current price sits at 34% of that range, 54.0% below the 52-week high.
- That makes 4 straight losses.
Oct 16, 2026 — CNSP slides 6.3% to $4.85, a 1-month low on 2.3x normal volume
- Closed at $4.85, -6.30% vs the prior close of $5.18. Day range $4.65–$5.00, opened at $5.00.
- Volume was 13.23K shares, 2.3x its 50-day average of 5.82K — unusually heavy trading.
- Price is -11.2% vs its 50-day average ($5.46) and +4.7% vs its 200-day average ($4.63).
- 52-week range $1.90–$10.54; today's close sits at 34% of that range, 54.0% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 — CNSP slides 3.2% to $5.18
- Closed at $5.18, -3.23% vs the prior close of $5.35. Day range $5.18–$5.18, opened at $5.18.
- Volume was 900 shares, 0.2x its 50-day average of 5.85K — lighter than usual.
- Price is -5.3% vs its 50-day average ($5.47) and +11.7% vs its 200-day average ($4.64).
- 52-week range $1.90–$10.54; today's close sits at 38% of that range, 50.9% below the 52-week high.
Oct 14, 2026 — CNSP ends flat (+0.0%) to $5.35
- Closed at $5.35, +0.00% vs the prior close of $5.35. Day range $5.35–$5.35, opened at $5.35.
- Price is -2.2% vs its 50-day average ($5.47) and +15.4% vs its 200-day average ($4.64).
- 52-week range $1.90–$10.54; today's close sits at 40% of that range, 49.2% below the 52-week high.
Oct 13, 2026 — CNSP jumps 3.1% to $5.35 on 2.5x normal volume
- Closed at $5.35, +3.08% vs the prior close of $5.19. Day range $5.00–$5.40, opened at $5.13.
- Volume was 14.20K shares, 2.5x its 50-day average of 5.78K — unusually heavy trading.
- Price is -2.2% vs its 50-day average ($5.47) and +15.3% vs its 200-day average ($4.64).
- 52-week range $1.90–$10.54; today's close sits at 40% of that range, 49.2% below the 52-week high.
Oct 12, 2026 — CNSP dips 3.0% to $5.19, 3 down days in a row
- Closed at $5.19, -2.99% vs the prior close of $5.35. Day range $5.03–$5.40, opened at $5.34.
- Volume was 6.20K shares, 1.1x its 50-day average of 5.88K.
- Price is -5.3% vs its 50-day average ($5.48) and +11.8% vs its 200-day average ($4.64).
- 52-week range $1.90–$10.54; today's close sits at 38% of that range, 50.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — CNSP ends flat (+0.0%) to $5.35
- Closed at $5.35, +0.00% vs the prior close of $5.35. Day range $5.34–$5.35, opened at $5.35.
- Volume was 1.20K shares, 0.2x its 50-day average of 5.92K — lighter than usual.
- Price is -2.6% vs its 50-day average ($5.49) and +15.1% vs its 200-day average ($4.65).
- 52-week range $1.90–$10.56; today's close sits at 40% of that range, 49.3% below the 52-week high.
Oct 8, 2026 — CNSP dips 1.5% to $5.35
- Closed at $5.35, -1.47% vs the prior close of $5.43. Day range $5.35–$5.36, opened at $5.36.
- Volume was 1.80K shares, 0.3x its 50-day average of 5.95K — lighter than usual.
- Price is -2.4% vs its 50-day average ($5.48) and +14.9% vs its 200-day average ($4.66).
- 52-week range $1.90–$10.59; today's close sits at 40% of that range, 49.5% below the 52-week high.
Oct 7, 2026 — CNSP rises 2.4% to $5.43
- Closed at $5.43, +2.41% vs the prior close of $5.30. Day range $5.08–$5.44, opened at $5.35.
- Volume was 2.70K shares, 0.5x its 50-day average of 5.99K — lighter than usual.
- Price is -0.8% vs its 50-day average ($5.48) and +16.5% vs its 200-day average ($4.66).
- 52-week range $1.90–$10.59; today's close sits at 41% of that range, 48.7% below the 52-week high.
Oct 6, 2026 — CNSP ends flat (+0.0%) to $5.30
- Closed at $5.30, +0.04% vs the prior close of $5.30. Day range $5.30–$5.45, opened at $5.40.
- Volume was 6.20K shares, 1.0x its 50-day average of 5.93K.
- Price is -3.1% vs its 50-day average ($5.47) and +13.6% vs its 200-day average ($4.67).
- 52-week range $1.90–$10.59; today's close sits at 39% of that range, 49.9% below the 52-week high.
Oct 5, 2026 — CNSP dips 0.5% to $5.30
- Closed at $5.30, -0.47% vs the prior close of $5.32. Day range $5.30–$5.50, opened at $5.50.
- Volume was 2.00K shares, 0.3x its 50-day average of 6.05K — lighter than usual.
- Price is -3.0% vs its 50-day average ($5.46) and +13.4% vs its 200-day average ($4.68).
- 52-week range $1.90–$10.59; today's close sits at 39% of that range, 49.9% below the 52-week high.
Oct 2, 2026 — CNSP rises 1.6% to $5.32
- Closed at $5.32, +1.62% vs the prior close of $5.24. Day range $5.11–$5.40, opened at $5.23.
- Volume was 10.90K shares, 1.8x its 50-day average of 6.15K.
- Price is -2.5% vs its 50-day average ($5.46) and +13.6% vs its 200-day average ($4.69).
- 52-week range $1.90–$10.59; today's close sits at 39% of that range, 49.7% below the 52-week high.
- SEC filings that day: 8-K.
CNSP bull case vs bear case (from the data)
- Price is +4.8% vs its 200-day average — above the long-term trend line.
- Insiders made 8 open-market purchases in the last 12 months.
- Price is -11.0% vs its 50-day average — short-term trend is down.
- Latest fiscal-year net income: loss of $15.85M.
- Share count up 154.4% in a year (dilution).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
CNSP latest news & SEC filings
Every SEC filing by or about CNSP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Aug 25, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 21, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Fisher Michal bought 2,000 shares at $5.00 (≈$10.00K) on May 18, 2026
- Fisher Michal bought 2,000 shares at $5.00 (≈$10.00K) on May 18, 2026
- Fisher Michal bought 2,000 shares at $5.00 (≈$10.00K) on May 18, 2026
- Fisher Michal bought 2,000 shares at $5.00 (≈$10.00K) on May 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 18, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$2.59M (prior year -$2.38M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.38 (prior year -$6.42) (loss narrowed vs Jun 30, 2025)
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade CNSP
- Last results release: May 16, 2024 (8-K Item 2.02). Previous ones: Apr 1, 2024, Nov 15, 2023, Aug 14, 2023. Based on that rhythm, the next report is likely around Aug 15, 2024 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.24% (largest 8.0%).
- Liquidity: about 4.02K shares (≈$19.50K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.85 vs a range of $1.90–$10.54 (34% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:12 on Jul 22, 2025, 1:50 on Feb 21, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Faith L. Charles bought 7,100 shares on May 18, 2026.
- Latest filings: 8-K Oct 2, 2026; 10-Q Aug 12, 2026; 8-K Jul 2, 2026.
- Share count: 1.46M shares outstanding (Aug 11, 2026), +154.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CNSP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 4.85 | 4.85 | 4.85 | 4.85 | 400 |
| Oct 16, 2026 | 4.98 | 5.00 | 4.65 | 4.85 | 13.40K |
| Oct 15, 2026 | 5.18 | 5.18 | 5.18 | 5.18 | 900 |
| Oct 14, 2026 | 5.35 | 5.35 | 5.35 | 5.35 | 0 |
| Oct 13, 2026 | 5.13 | 5.40 | 5.00 | 5.35 | 14.20K |
| Oct 12, 2026 | 5.34 | 5.40 | 5.03 | 5.19 | 6.20K |
| Oct 9, 2026 | 5.35 | 5.35 | 5.34 | 5.35 | 1.20K |
| Oct 8, 2026 | 5.36 | 5.36 | 5.35 | 5.35 | 1.80K |
| Oct 7, 2026 | 5.35 | 5.44 | 5.08 | 5.43 | 2.70K |
| Oct 6, 2026 | 5.40 | 5.45 | 5.30 | 5.30 | 6.20K |
| Oct 5, 2026 | 5.50 | 5.50 | 5.30 | 5.30 | 2.00K |
| Oct 2, 2026 | 5.23 | 5.40 | 5.11 | 5.32 | 10.90K |
| Oct 1, 2026 | 5.35 | 5.35 | 5.24 | 5.24 | 900 |
| Sep 30, 2026 | 5.25 | 5.47 | 4.93 | 5.30 | 8.00K |
| Sep 29, 2026 | 4.91 | 4.91 | 4.91 | 4.91 | 500 |
| Sep 28, 2026 | 4.98 | 5.11 | 4.97 | 5.11 | 2.40K |
| Sep 25, 2026 | 5.21 | 5.21 | 4.93 | 4.93 | 1.30K |
| Sep 24, 2026 | 5.15 | 5.15 | 5.15 | 5.15 | 1.80K |
| Sep 23, 2026 | 5.15 | 5.15 | 5.15 | 5.15 | 2.90K |
| Sep 22, 2026 | 5.24 | 5.24 | 5.00 | 5.24 | 2.70K |
About CNS Pharmaceuticals
CNS Pharmaceuticals (CNSP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in HOUSTON, TX. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1729427.
CNSP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Faith L. Charles | Director | May 20, 2026 |
| John M Climaco | Chief Executive Officer | Nov 19, 2025 |
| Bettina M. Cockroft | Director | Nov 19, 2025 |
| Michal Fisher | Director | Aug 18, 2026 |
| Jerzy Gumulka | Director | Nov 19, 2025 |
| Jeffry R. Keyes | Director | Nov 19, 2025 |
| Amy Mahery | Director | Nov 19, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John M Climaco | Chief Executive Officer | Nov 19, 2025 |
| Christopher Downs | Chief Financial Officer | Nov 19, 2025 |
| Eric Faulkner | Chief Technology Officer | Mar 4, 2026 |
| Rami Levin | CEO and President | Aug 18, 2026 |
| Steve O'Loughlin | Chief Financial Officer | Mar 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 18, 2026 | Faith L. Charles | Buy | 7,100 | $4.79 |
| May 18, 2026 | Faith L. Charles | Buy | 7,100 | $4.79 |
| May 18, 2026 | Faith L. Charles | Buy | 7,100 | $4.79 |
| May 18, 2026 | Faith L. Charles | Buy | 7,100 | $4.79 |
| May 18, 2026 | Michal Fisher | Buy | 2,000 | $5.00 |
| May 18, 2026 | Michal Fisher | Buy | 2,000 | $5.00 |
| May 18, 2026 | Michal Fisher | Buy | 2,000 | $5.00 |
| May 18, 2026 | Michal Fisher | Buy | 2,000 | $5.00 |
CNSP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-15.85M | -35.75 | $-13.81M |
| Dec 31, 2024 | — | $-14.86M | -466.89 | $-17.11M |
| Dec 31, 2023 | — | $-18.85M | -12,509.11 | $-14.14M |
| Dec 31, 2022 | — | $-15.27M | -11.22 | $-10.56M |
| Dec 31, 2021 | — | $-14.50M | -16.50 | $-13.54M |
Latest balance sheet: total assets $21.94M, total liabilities $3.74M, cash $19.98M (as of Jun 30, 2026).
CNSP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 16, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
| Nov 15, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
| May 15, 2023 | 8-K Item 2.02 (results) | — |
| Aug 15, 2022 | 8-K Item 2.02 (results) | — |
| May 16, 2022 | 8-K Item 2.02 (results) | — |
| Mar 3, 2022 | 8-K Item 2.02 (results) | — |
| Aug 13, 2021 | 8-K Item 2.02 (results) | — |
| Mar 12, 2020 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on CNSP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.